Tenofovir Disoproxil
Back to searchMolecule Structure
Scientific Name
Tenofovir Disoproxil
Description of the Drug
Tenofovir disoproxil is a nucleotide analog reverse transcriptase inhibitor used in the treatment of Hepatitis B infection and used in the management of HIV-1 infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00300
http://www.drugbank.ca/drugs/DB00300
Brand Name(s)
Viread
Company Owner(s)
Cipla Ltd, Macleods Pharmaceuticals Ltd, Laurus Labs Ltd, Gilead Sciences Inc, Mylan Pharmaceuticals Inc, Chartwell Life Molecules Llc, Zydus Pharmaceuticals Usa Inc, Merck Sharp And Dohme Corp A Sub Of Merck And Co Inc, Teva Pharmaceuticals Usa Inc, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase | SINGLE PROTEIN | INHIBITOR | CHEMBL247 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL52793 | ||
| DrugBank | DB00300 | ||
| PubChem: Thomson Pharma | 14885075 | ||
| PubChem | 5481350 | ||
| Nikkaji | J898.676B | ||
| EPA CompTox Dashboard | DTXSID5052757 | ||
| DrugCentral | 2593 | ||
| Brenda | 165908 | ||
| ChemicalBook | CB0949152 | ||
| rxnorm | TENOFOVIR DISOPROXIL | TENOFOVIR DISOPROXIL FUMARATE | VIREAD |
| ChEBI | 63717 | ||
| ZINC | ZINC000003929022 |
